Infectious Disease

Top Story

Genetic marker may help identify patients at high risk for severe influenza

Genetic marker may help identify patients at high risk for severe influenza
July 25, 2017

Adults and children with a particular inherited variation in the IFITM3 gene were more than twice as likely to develop severe influenza than patients without the gene variation, according to research published in Nature Medicine.

Researchers said the marker, known as rs3448114, could be used to help identify patients at risk for severe and potentially life-threatening influenza infections.

In the Journals

FMT ‘highly effective’ for recurrent, refractory C. difficile infection, regardless of preparation, delivery

July 24, 2017
Fecal microbiota transplantation was highly effective for treating recurrent or refractory Clostridium difficile infection, independent of preparation and delivery…
Meeting News

Child with HIV suppresses virus for more than 8 years without ART

July 24, 2017
A South African child who was diagnosed with HIV as an infant has suppressed the virus for the past 8 1/2 years without treatment, researchers said. The child was…
In the Journals

Occult HBV does not affect HCC resection outcomes

July 24, 2017
The presence of hepatitis B core antibody, or HBcAb, did not affect the outcomes of hepatic resection in patients with either hepatitis C-related or non-B, non-C…
Meeting News

LATTE-2: Two-drug injectable ART regimen as effective as three-drug oral regimen

July 24, 2017
A two-drug injectable ART regimen received monthly or bimonthly is as effective in maintaining HIV suppression as a three-drug oral regimen through 96 weeks, according…
More News Headlines »
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »

FDA approves Baxdela for ABSSSIs; more treatments in the pipeline

Infectious Disease News, July 2017
The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute…
More »
Resource Centers
ASM Microbe

ASM Microbe

Video
Meeting News

VIDEO: Vaccine significantly reduces risk for influenza-related death in children

June 5, 2017
More »
Advertisement
Advertisement